Similarly, recent studies have consistently reported that the Lachnospiraceae ND3007 group is significantly reduced in patients with MASLD, with lower levels linked to hepatic fat accumulation and elevated liver enzymes such as ALT and AST [42–44]. This evidence concerns the gene GPT and metabolic dysfunction-associated steatotic liver disease.